{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:46:31Z","timestamp":1772538391050,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s11010-012-1461-1","type":"journal-article","created":{"date-parts":[[2012,9,23]],"date-time":"2012-09-23T05:50:33Z","timestamp":1348379433000},"page":"199-210","source":"Crossref","is-referenced-by-count":8,"title":["Serum protein N-glycan alterations of diethylnitrosamine-induced hepatocellular carcinoma mice and their evolution after inhibition of the placental growth factor"],"prefix":"10.1007","volume":"372","author":[{"given":"Bram","family":"Blomme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Heindryckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Marie","family":"Stassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Colle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,24]]},"reference":[{"issue":"Suppl 3","key":"1461_CR1","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S1590-8658(10)60507-5","volume":"42","author":"H Nordenstedt","year":"2010","unstructured":"Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in Hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):S206\u2013S214","journal-title":"Dig Liver Dis"},{"key":"1461_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2005-871194","volume":"25","author":"M Sherman","year":"2005","unstructured":"Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25:143\u2013154","journal-title":"Semin Liver Dis"},{"key":"1461_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(86)80075-7","volume":"2","author":"F Piccinino","year":"1986","unstructured":"Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2:165\u2013173","journal-title":"J Hepatol"},{"key":"1461_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1006","volume":"10","author":"N Callewaert","year":"2004","unstructured":"Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R (2004) Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 10:429\u2013434","journal-title":"Nat Med"},{"key":"1461_CR5","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.21855","volume":"46","author":"XE Liu","year":"2007","unstructured":"Liu XE, Desmyter L, Gao CF et al (2007) N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 46:1426\u20131435","journal-title":"Hepatology"},{"key":"1461_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep.23613","volume":"52","author":"J Xu","year":"2010","unstructured":"Xu J, Yun X, Jiang J et al (2010) Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage. Hepatology 52:142\u2013154","journal-title":"Hepatology"},{"key":"1461_CR7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.0815-9319.2004.03473.x","volume":"19","author":"JK Shim","year":"2004","unstructured":"Shim JK, Lee YC, Chung TH, Kim CH (2004) Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus. J Gastroenterol Hepatol 19:1374\u20131387","journal-title":"J Gastroenterol Hepatol"},{"key":"1461_CR8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1046\/j.1440-1746.2001.02612.x","volume":"16","author":"M Yanagi","year":"2001","unstructured":"Yanagi M, Aoyagi Y, Suda T, Mita Y, Asakura H (2001) N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 16:1282\u20131289","journal-title":"J Gastroenterol Hepatol"},{"key":"1461_CR9","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/1078-0432.CCR-07-5261","volume":"15","author":"R Goldman","year":"2009","unstructured":"Goldman R, Ressom HW, Varghese RS et al (2009) Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 15:1808\u20131813","journal-title":"Clin Cancer Res"},{"key":"1461_CR10","doi-asserted-by":"crossref","first-page":"26706","DOI":"10.1074\/jbc.271.43.26706","volume":"271","author":"R Kang","year":"1996","unstructured":"Kang R, Saito H, Ihara Y et al (1996) Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem 271:26706\u201326712","journal-title":"J Biol Chem"},{"key":"1461_CR11","doi-asserted-by":"crossref","first-page":"22941","DOI":"10.1074\/jbc.274.33.22941","volume":"274","author":"J Ko","year":"1999","unstructured":"Ko J, Miyoshi E, Noda K et al (1999) Regulation of the GnT-V promoter by transcription Ets-1 in various cancer cell lines. J Biol Chem 274:22941\u201322948","journal-title":"J Biol Chem"},{"key":"1461_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1247\/csf.26.19","volume":"26","author":"Y Sato","year":"2001","unstructured":"Sato Y (2001) Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct 26:19\u201324","journal-title":"Cell Struct Funct"},{"key":"1461_CR13","first-page":"119","volume":"140","author":"N Wernert","year":"1992","unstructured":"Wernert N, Raes MB, Lassalle P et al (1992) c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140:119\u2013127","journal-title":"Am J Pathol"},{"key":"1461_CR14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/MCB.16.2.538","volume":"16","author":"B Yang","year":"1996","unstructured":"Yang B, Hauser C, Henkel G et al (1996) Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets-1 and c-Ets-2. Moll Cell Biol 16:538\u2013547","journal-title":"Moll Cell Biol"},{"key":"1461_CR15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1101\/gad.14.3.366","volume":"14","author":"D Cowley","year":"2000","unstructured":"Cowley D, Graves B (2000) Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. Genes Dev 14:366\u2013376","journal-title":"Genes Dev"},{"key":"1461_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1126\/science.1111915","volume":"309","author":"M Pufall","year":"2005","unstructured":"Pufall M, Lee G, Nelson M et al (2005) Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science 309:142\u2013145","journal-title":"Science"},{"key":"1461_CR17","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","volume":"88","author":"D Maglione","year":"1991","unstructured":"Maglione D, Guerriero V, Viglietto G, Dellibovi P, Persico M (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267\u20139271","journal-title":"Proc Natl Acad Sci USA"},{"key":"1461_CR18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","volume":"131","author":"C Fischer","year":"2007","unstructured":"Fischer C, Jonckx B, Mazzone M et al (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131:463\u2013475","journal-title":"Cell"},{"key":"1461_CR19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","volume":"141","author":"S Veire Van de","year":"2010","unstructured":"Van de Veire S, Stalmans I, Heindryckx F et al (2010) Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141:178\u2013190","journal-title":"Cell"},{"key":"1461_CR20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1021\/pr900397n","volume":"9","author":"Z Tang","year":"2010","unstructured":"Tang Z, Varghese R, Bekesova S et al (2010) Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res 9:104\u2013112","journal-title":"J Proteome Res"},{"key":"1461_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1476-4598-9-219","volume":"9","author":"F Heindryckx","year":"2010","unstructured":"Heindryckx F, Mertens K, Charette N et al (2010) Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma. Mol Cancer 9:219\u2013232","journal-title":"Mol Cancer"},{"key":"1461_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nprot.2006.60","volume":"1","author":"W Laroy","year":"2006","unstructured":"Laroy W, Contreras R, Callewaert N (2006) Glycome mapping on DNA sequencing equipment. Nat Protoc 1:397\u2013405","journal-title":"Nat Protoc"},{"key":"1461_CR23","doi-asserted-by":"crossref","first-page":"G833","DOI":"10.1152\/ajpgi.00228.2010","volume":"300","author":"B Blomme","year":"2011","unstructured":"Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H (2011) Alterations of serum protein N-glycosylation in two models of chronic liver disease are hepatocyte and not B cell driven. Am J Physiol Gastrointest Liver Physiol 300:G833\u2013G842","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1461_CR24","doi-asserted-by":"crossref","first-page":"G615","DOI":"10.1152\/ajpgi.00414.2009","volume":"298","author":"B Blomme","year":"2010","unstructured":"Blomme B, Van Steenkiste C, Vanhuysse J, Colle I, Callewaert N, Van Vlierberghe H (2010) Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans. Am J Physiol Gastrointest Liver Physiol 298:G615\u2013G624","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1461_CR25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/prca.200900133","volume":"4","author":"A Klein","year":"2010","unstructured":"Klein A, Carre Y, Louvet A, Michalski JC, Morelle W (2010) Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients. Proteomics Clin Appl 4:379\u2013393","journal-title":"Proteomics Clin Appl"},{"key":"1461_CR26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1074\/mcp.M800470-MCP200","volume":"8","author":"D Vanderschaeghe","year":"2009","unstructured":"Vanderschaeghe D, Laroy W, Sablon E et al (2009) GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics 8:986\u2013994","journal-title":"Mol Cell Proteomics"},{"key":"1461_CR27","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1478-3231.2010.02279.x","volume":"30","author":"XE Liu","year":"2010","unstructured":"Liu XE, Dewaele S, Vanhooren V et al (2010) Alteration of N-glycome in diethylnitrosamine-induced hepatocellular carcinoma mice: a non-invasive monitoring tool for liver cancer. Liver Int 30:1221\u20131228","journal-title":"Liver Int"},{"key":"1461_CR28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1309\/RAVV-8NM1-CJB7-GJFR","volume":"114","author":"Y Ito","year":"2000","unstructured":"Ito Y, Miyoshi E, Takeda T et al (2000) Expression and possible role of ets-1 in hepatocellular carcinoma. Am J Clin Pathol 114:719\u2013725","journal-title":"Am J Clin Pathol"},{"key":"1461_CR29","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1021\/ac101560a","volume":"82","author":"D Vanderschaeghe","year":"2010","unstructured":"Vanderschaeghe D, Szekr\u00e9nyes A, Wenz C et al (2010) High-throughput profiling of the serum N-glycome on capillary electrophoresis microfluidics systems: towards clinical implication of the GlycoHepatoTest. Anal Chem 82:7408\u20137415","journal-title":"Anal Chem"},{"key":"1461_CR30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/glycob\/cwp200","volume":"20","author":"S Takamatsu","year":"2010","unstructured":"Takamatsu S, Antonopoulos A, Ohtsubo K et al (2010) Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice. Glycobiology 20:485\u2013497","journal-title":"Glycobiology"},{"key":"1461_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/JOE-10-0237","volume":"208","author":"R Mendoza","year":"2011","unstructured":"Mendoza R, Moody E, Enriquez M, Mejia S, Thordarson G (2011) Tumorigenicity of MCF-7 human breast cancer cells lacking the p38\u03b1 mitogen-activated protein kinase. J Endocrinol 208:11\u201319","journal-title":"J Endocrinol"},{"key":"1461_CR32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cellsig.2009.11.011","volume":"22","author":"Y Hsu","year":"2010","unstructured":"Hsu Y, Meng X, Ou L, Ip M (2010) Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells. Cell Signal 22:590\u2013599","journal-title":"Cell Signal"},{"key":"1461_CR33","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.4161\/cc.6.20.4774","volume":"6","author":"L Hui","year":"2007","unstructured":"Hui L, Bakiri L, Stepniak E, Wagner E (2007) P38 alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 6:2429\u20132433","journal-title":"Cell Cycle"},{"key":"1461_CR34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ng2033","volume":"39","author":"L Hui","year":"2007","unstructured":"Hui L, Bakiri L, Mairhorfer A et al (2007) P38 alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39:741\u2013749","journal-title":"Nat Genet"},{"key":"1461_CR35","doi-asserted-by":"crossref","first-page":"20995","DOI":"10.1074\/jbc.M407060200","volume":"280","author":"M McMullen","year":"2005","unstructured":"McMullen M, Bryant P, Glembotski C, Vincent P, Pumiglia K (2005) Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J Biol Chem 280:20995\u201321003","journal-title":"J Biol Chem"},{"key":"1461_CR36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1096\/fj.02-0329fje","volume":"17","author":"K Issbr\u00fccker","year":"2003","unstructured":"Issbr\u00fccker K, Marti H, Hippenstiel S (2003) p38 MAP kinase\u2014a molecular switch between VEGF-induced angiogenesis and vascular permeability. FASEB J 17:262\u2013264","journal-title":"FASEB J"},{"key":"1461_CR37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0006-291X(02)00677-0","volume":"295","author":"A Luttun","year":"2002","unstructured":"Luttun A, Brusselmans K, Fukao H et al (2002) Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun 295:428\u2013434","journal-title":"Biochem Biophys Res Commun"},{"key":"1461_CR38","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.onc.1208234","volume":"24","author":"M Vetter","year":"2005","unstructured":"Vetter M, Blumenthal S, Lindemann R (2005) Ets1 is an effector of protein kinase C\u03b1 in cancer cells. Oncogene 24:650\u2013661","journal-title":"Oncogene"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-012-1461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-012-1461-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-012-1461-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T14:03:51Z","timestamp":1643465031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-012-1461-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,24]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1461"],"URL":"https:\/\/doi.org\/10.1007\/s11010-012-1461-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,24]]}}}